All Policy articles – Page 41
-
OpinionThe public: clients of science?
Should scientific advice inform or instruct? Steve Fuller says scientists should stick to the facts and let the public decide
-
News
Home office to help student job seekers
Foreign PhD students will get a 12 month grace period to find a job after end of course
-
BusinessCan the UK fund CCS?
EU is offering €1.5 billion in funding but lack of co-ordination with UK scheme threatens participation
-
BusinessObama re-election worries chemical industry
A second term could mean more aggressive environmental regulations and an emboldened EPA, chemical industry groups warn
-
-
News
Attempts to reform Croatian science stall
Controversy over changes to promotions and retirement age send the reforms back to the drawing board
-
NewsLiberal Democrats pledge support for UK science
Party pass science policy paper unanimously at its conference in Brighton
-
NewsPresidential candidates search for the right chemistry
In the quest for the US presidency, Obama has greater credibility with science groups, Romney has more industry support
-
OpinionProtecting patients at all costs
Suffering stagnant output, and beset by patent expiries and spiralling costs, drug discovery is in poor health. Simon Campbell prescribes a remedy
-
-
BusinessIrish pharma exports tumble
Seven of the top 10 drugs going off patent between 2011 and 2014 are produced in Ireland
-
NewsNew law to increase autonomy of Ukrainian universities
Students protest draft legislation that they say will allow the commercialization of higher education in the country
-
NewsCalls to match skills to industry
Universities are not producing enough science graduates with the skills needed by UK industry, Lord’s report claims
-
News
Russia to ease qualification vetting bureaucracy
Simpler recognition process for foreign qualifications planned to attract more skilled workers
-
Feature
Chemists in the House
Laura Howes talks to politicians who have made the move from the lab to the benches of power
-
Business
GSK to build £350m factory in UK
GlaxoSmithKline (GSK) has announced £350 million plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria
-
Business
Irish government plans to pick winners in research
Science funding will be targeted to areas that will deliver the biggest return on investment
-
News
Double whammy blow to US nuclear science
Los Alamos National Lab’s budget will be cut by 11% and an actinide chemistry facility postponed
-
NewsTax policies to target research centres in China
Imposing tax on imported instruments angers industry